Clinical Trial Update: A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase I clinical trial update for ART101 injection in healthy adults to evaluate safety and tolerability in hypertension; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ART101 Injection (ART101)

Snippet

Sponsor: Arnatar Therapeutics, Inc. | Conditions: Hypertension (HTN) | Phase 1 | Status: COMPLETED